GALWAY, IRELAND--November 2, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Novartis International AG (NYSE:NVS) (Basel, Switzerland) has inked a new deal to boost the manufacturing capacity of the Pfizer-BioNTech COVID-19 vaccine, COMINARTY, at its sterile fill-finish plant in Ljubljana, Slovenia. Within this article: Details new manufacturing deal, new location, estimated capacity, related CureVac COVID-19 vaccine news
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!